PursueCare Completes Series B Fundraising Round and Acquires Digital Therapeutics Developed by Pear Therapeutics, Inc.
The Fundraising and Acquisition of Digital Therapeutics for SUD Strengthens PursueCare’s Ability to Provide Care for Individuals with Addiction
PursueCare, a digital addiction treatment provider, today announced the completion of a Series B fundraising round totaling $20 million. The Series B round was led by T.Rx Capital and Yamaha Motor Ventures, with participation from Seyen Capital and OCA Ventures. The proceeds from the financing will support PursueCare’s ongoing collaborative care initiatives with health systems across 11 states, as well as expansion into value-based care with Medicaid managed care and other heal...
Source: EMR and HIPAA - January 5, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Corey McCann Health IT Acquisitions Healthcare M&A Nicholas Mercadante OCA Ventures Pear Therapeutics PursueCare reSET reSET-O Seyen Capital T.Rx Capital Yamaha Motor Ventures Source Type: blogs
Navigating The New A2P 10DLC Regulations in Healthcare: A Guide for Healthcare Text Messaging
The following is a guest article by Dr. Lea McMahon LPC, EdD, Chief Clinic Officer at Symetria Recovery
Even in the sensitive healthcare industry, most patients prefer to communicate with their providers via text message instead of email, calls, or app messages.
New A2P 10DLC regulations require all businesses to register both their company and their specific text messages.
Quick note: A2P stands for Application-to-Person and essentially applies to all text messages that aren’t sent directly from a phone.
Starting September 1, 2023, A2P text messages that were not approved through this new process were blocked. For ...
Source: EMR and HIPAA - September 14, 2023 Category: Information Technology Authors: Guest Author Tags: Ambulatory Clinical Communication and Patient Experience Health IT Company Healthcare IT Hospital - Health System IT Infrastructure and Dev Ops LTPAC Regulations A2P 10DLC Brand Registration Campaign Registration Dr. Lea McMahon Source Type: blogs
Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?
We described above how changes in opioid policy aimed at reducing Washington State’s Medicaid and Workers Compensation costs contributed to an increase in methadone deaths between 2003 and late 2014 (23-25). Focusing on similar cost reductions, the Centers for Medicar e and Medicaid Services (CMS) proposed rules for 2019 including several directives intended to reduce " Opioid Overutilization, ” including adoption of the “90 morphine milligram equivalent (MME) threshold cited by the 2016 CDC Opioid Guideline (147, 148). Simply put, reduced prescribing reduces costs for prescribed medications.Chou received research fu...
Source: Pallimed: A Hospice and Palliative Medicine Blog - September 12, 2022 Category: Palliative Care Tags: health policy judy kollas opioids research schechtman Source Type: blogs
Protect the rights of licensed health care workers to take buprenorphine
Early in my addiction medicine fellowship, I met a patient for the second time while shadowing another physician in their practice. The patient was a former nurse with opioid use disorder on maintenance therapy with buprenorphine (commonly called Suboxone, the original brand name of a formulation combined with naloxone), a partial opioid agonist that isRead more …Protect the rights of licensed health care workers to take buprenorphine originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - July 13, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/arielle-gerard" rel="tag" data-wpel-link="internal" > Arielle Gerard, MD, MPH < /a > < /span > Tags: Meds Psychiatry Source Type: blogs
Allow patients to continue their opioid of choice while starting microdoses of buprenorphine
Twenty-six hours into the shakes, sweats, crawling anxiety, and gripping nausea of opioid withdrawal, Faye caves in and takes a couple of fentanyl tabs. She knows that she must tough out a couple of days without fentanyl to start Suboxone (buprenorphine/naloxone) through a medication-assisted treatment program, but the sickness gets the better of her. ThoseRead more …Allow patients to continue their opioid of choice while starting microdoses of buprenorphine originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - June 16, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/julie-craig" rel="tag" data-wpel-link="internal" > Julie Craig, MD < /a > < /span > Tags: Meds Pain Management Source Type: blogs
Inside Boulder Care ’s $36 Million Series B & Scaling Telehealth Addiction Treatment in Medicaid
BY JESSICA DaMASSA, WTF HEALTH
Telehealth addiction treatment clinic Boulder Care just closed a $36 million Series B. I’ve got Founder & CEO Stephanie Strong here to talk about the virtual care company’s medication-assisted approach to opioid and alcohol use disorder treatment, and its growing-bigger-by-the-day presence in the Medicaid market.
In fact, more than 95% of Boulder Care’s revenue comes in from Managed Medicaid plans, and this focus on making medications like Suboxone accessible to traditionally marginalized patients is not only better for patients (drugs like these can cut all-cause mortality r...
Source: The Health Care Blog - June 13, 2022 Category: Consumer Health News Authors: matthew holt Tags: Health Tech WTF Health Bicycle Health Boulder Care Cerebral Medicaid Mental Health Stephanie Strong substance use disorders Source Type: blogs
New National Drug Control Strategy Takes Some Positive Steps But Can Go Much Further
Jeffrey A. SingerIn the wake of a Marchreport from the Centers for Disease Control and Prevention (CDC) that drug overdose deaths climbed to a record 106,000 for the 12 months ending November 2021 (last November the agency reported100,000 overdose deaths for the 12 months ending April 2021), the White House Office of National Drug Control Policy published a National Drug Control Strategy today.On the positive side is ONDCP ’s new appreciation for the benefits ofharm reduction for reducing the risk of death and disease from using drugs obtained in the dangerous black market. The strategy includes a&nbs...
Source: Cato-at-liberty - April 21, 2022 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
August 2021: Adulterant in Fentanyl Complicates OD
A 38-year-old woman with opioid use disorder presented to the emergency department after an unintentional overdose. EMS said the patient was found with decreased respirations, and she was given 2 mg intranasal naloxone. She was awake, alert, and oriented x 3 in the emergency department.She reported that she used one bundle of fentanyl/heroin a day intravenously and that she had recently been hospitalized for four weeks for a wound infection. She stated that she used her usual dosage of fentanyl/heroin on discharge, not realizing how much her tolerance had decreased.She also said the fentanyl contained “tranq" (xy...
Source: The Tox Cave - August 2, 2021 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs
The Real Reason Fentanyl is So Dangerous
Fentanyl plays a role in more and more opioid overdose deaths. Most fentanyl used ‘on the streets’ starts in China, with precursors shipped to California or Mexico before distribution throughout the US. Fentanyl acts very potently at the same receptors as heroin, morphine, and oxycodone. Reports of overdose deaths caused by fentanyl usually blame potency, but the real reason for fentanyl’s outsized role in overdose is rarely mentioned – at least outside operating rooms.
Fentanyl is as ubiquitous in the medical industry as it is on the street, in 50 microgram per cc, sterile vials rather than the ...
Source: Suboxone Talk Zone - June 16, 2021 Category: Addiction Authors: admin Tags: Uncategorized Source Type: blogs
If Lawmakers Really Want to “Follow the Science” They Will Repeal Codified Opioid Guidelines
This study documents a relationship between opioid prescribing and opioid overdose in a large, national, prospective cohort of individuals receiving opioid therapy for a variety of medical conditions. The risk of opioid overdose should continue to be evaluated relative to the need to reduce pain and suffering and be considered along with other risk factors.University of Alabama Professor of Medicine Stefan Kerteszpointed out thatfollow up research led by Bohnert found the median overdose dosage was 60 MMEs and 86 percent occurred under 90 MMEs. Yet he cautioned policymakers:Reliance on a simple binary dose metric is an ext...
Source: Cato-at-liberty - May 24, 2021 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
PROP s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences
ConclusionDespite being turned back from an effort to bluntly reduce opioid prescribing by the FDA in 2013 based on a lack of scientific evidence for its position (17,18), PROP has had a disproportionate effect on opioid policy in the Untied States for almost a decade. PROP found a willing federal regulatory partner in the CDC, and while PROP may not have secretly written the 2016 CDC Pain Guidelines (75), they certainly enjoyed disproportionate representation on CDCs review panels and Core Expert Group (23-25) in a process that lacked transparency (22, 23, 26, 27). When the CDC admitted that its Pain Guideline had been...
Source: Pallimed: A Hospice and Palliative Medicine Blog - May 3, 2021 Category: Palliative Care Tags: CDC health policy kollas opioids pain prop Source Type: blogs
PROP ’s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences
ConclusionDespite being turned back from an effort to bluntly reduce opioid prescribing by the FDA in 2013 based on a lack of scientific evidence for its position (17,18), PROP has had a disproportionate effect on opioid policy in the Untied States for almost a decade. PROP found a willing federal regulatory partner in the CDC, and while PROP may not have “secretly written” the 2016 CDC Pain Guidelines (75), they certainly enjoyed disproportionate representation on CDC’s review panels and Core Expert Group (23-25) in a process that lacked transparency (22, 23, 26, 27). When the CDC admitted that its Pain Guideline ha...
Source: Pallimed: A Hospice and Palliative Medicine Blog - May 3, 2021 Category: Palliative Care Tags: CDC health policy kollas opioids pain prop Source Type: blogs
“I Don’t Do Windows” Says the Maid. “I Don’t Do Machines” Says this Doctor – “But I Do Nudge Therapy”
By HANS DUVEFELT
The hackneyed windows phrase, about what a domestic employee will and will not do for an employer, represents a concept that applies to the life of a doctor, too.
Personally, I have to do Windows, the default computer system of corporate America, even though I despise it. But in my personal life I use iOS on my iPad and iPhone and very rarely use even my slick looking MacBook Pro. I use “tech” and machines as little as possible and I prefer that they work invisibly and intuitively.
In medicine, even in what used to be called “general practice”, you can’t very reasonably do everything for...
Source: The Health Care Blog - March 29, 2021 Category: Consumer Health News Authors: Christina Liu Tags: Medical Practice Physicians Primary Care Hans Duvefelt Source Type: blogs
Jealousy and missed opportunities in medicine
“Julie” began the telehealth encounter in her car, greeting me with a cheerful smile. The sun glimmered through the driver-side window, illuminating the water spots to sparkle like diamonds. “How are you doing with your suboxone dose? Do you feel that you need to go up, or are you happy with y our current dose?” I […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - February 20, 2021 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/anonymous" rel="tag" > Anonymous < /a > < /span > Tags: Education Psychiatry Source Type: blogs
After Moving Slightly Forward on Buprenorphine, Will We Shift Into Reverse?
Jeffrey A. SingerThe Department of Health and Human Services issuedrelaxed guidelines for physicians wishing to treat Opioid Use Disorder (OUD) with buprenorphine in the closing days of the Trump administration. While I arguedhere that the guidelines don ’t go far enough, it was nevertheless a step in the right direction.Even though outright repeal of the Drug Enforcement Administration ’s so‐called “X‐waiver,” required of health care practitioners wishing to treat OUD with buprenorphine receivedbipartisansupport in the last Congress, the Biden administration is consideringrescinding the new bup...
Source: Cato-at-liberty - February 1, 2021 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
